Gadolinium-free
contrast-enhanced
MRI.

All current MRI contrast agents cause accumulation of the rare earth element gadolinium in the brain and body of every patient. Gadolinium from MRI agents results in rising pollution of earth's surface waters, and the global gadolinium supply chain is controlled by China, creating a key vulnerability for vital healthcare systems.

Despite decades of growing concern this has remained an exceptionally difficult scientific problem: until now there have been no viable alternatives to fully replace existing MRI agents. RVP-001, designed to be a direct replacement for current standard of care MRI contrast agents, is based on manganese, a biocompatible element essential for life.

Our contrast agent is designed for impact across patients, the environment, and supply chain resilience, with the potential to transform a growing global market of 65 million doses per year.